Procedure
treatment protocol
treatment protocol is a medical procedure with 4 clinical trials. Currently 2 active trials ongoing.
Total Trials
4
Max Phase
—
Type
PROCEDURE
Molecule
—
Success Metrics
Active Trials
2(50%)
Phase Distribution
Ph phase_2
1
25%
Ph not_applicable
2
50%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Other(2)
Detailed Status
Active, not recruiting2
unknown2
Development Timeline
Analytics
Development Status
Total Trials
4
Active
2
Success Rate
N/A
Most Advanced
Phase 2
Trials by Phase
Phase 21 (33.3%)
N/A2 (66.7%)
Trials by Status
active_not_recruiting250%
unknown250%
Recent Activity
2 active trials
Showing 4 of 4
active_not_recruiting
Cohort Profile：The Shandong Adenomyosis Cohort of Population Undergoing Reproductive Technology (SAart)
NCT06604091
active_not_recruitingnot_applicable
Effectiveness of Physiotherapy After Stroke
NCT06165666
unknownnot_applicable
The Small Intestine Bacterial Overgrowth Study Pilot
NCT03588845
unknownphase_2
Bortezomib, Rituximab and Dexamethasone (BORID) for Relapsed/Refractory Mantle Cell Lymphoma
NCT00261612
Clinical Trials (4)
Showing 4 of 4 trials
NCT06604091
Cohort Profile：The Shandong Adenomyosis Cohort of Population Undergoing Reproductive Technology (SAart)
NCT06165666Not Applicable
Effectiveness of Physiotherapy After Stroke
NCT03588845Not Applicable
The Small Intestine Bacterial Overgrowth Study Pilot
NCT00261612Phase 2
Bortezomib, Rituximab and Dexamethasone (BORID) for Relapsed/Refractory Mantle Cell Lymphoma
All 4 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 4